American Association for Clinical Chemistry

TIANGEN to Participate in the 2022 AACC Meeting

Retrieved on: 
Friday, July 22, 2022
Association, Booth, CEO, Temperature, History, Solution, American Association, COVID-19, Sun, COVID-19 testing, AACC, Plant, American Association for Clinical Chemistry, Soil, Exhibition, PCR, Pharmaceutical industry, Phosphorus, Fine chemical

TIANGEN will primarily be showcasing the TGuide S16 Nucleic Acid Extractor series with a special display board and a prototype at Booth 957.

Key Points: 
  • TIANGEN will primarily be showcasing the TGuide S16 Nucleic Acid Extractor series with a special display board and a prototype at Booth 957.
  • The smart nucleic acid extractor can automatically purify nucleic acid from various animal tissues, plants, soil, stool and gel or PCR product.
  • Such feature makes it very suitable for scientific researchers that do small and medium throughput and various sample types.
  • "This participation in the AACC conference marks TIANGEN's first official appearance at a local exhibition in the United States," said Kefei Sun, CEO of TIANGEN.

DxPx Conference Expands Its Scope to the US in Cooperation With AACC, Clinical Lab Expo

Retrieved on: 
Friday, July 8, 2022
Technology, Biotechnology, Health, Finance, Banking, Pharmaceutical, Professional Services, Other Science, Research, Software, Networks, Health Technology, Science, Clinical Trials, List of life sciences, McDermott Will & Emery, Travel, Precision medicine, Nigeria Pitch Awards, Marketing, Growth, Cancer, Company, Industry, American Association for Clinical Chemistry, Awareness, Hygiene, Partnership, EU, Digital health, Technology, American Association, AACC, Health, Mass spectrometry, Degenerative disease, Physician, Society, Knowledge, Diagnosis, Conference, Video game, Public relations, Pharmaceutical industry, McCormick Place

The three-day partnering conference is taking place from July 26th to 28th, 2022 at the AACC Clinical Lab Expo in McCormick Place, Chicago.

Key Points: 
  • The three-day partnering conference is taking place from July 26th to 28th, 2022 at the AACC Clinical Lab Expo in McCormick Place, Chicago.
  • What's new this year is the strategic partnership with AACC (American Association for Clinical Chemistry) and the DxPx Startup City which features innovative startups and growth companies.
  • DxPx is proud to have AACC as a partner for this year's DxPx and looks forward to filling the in-person days with panel discussions and fireside chats.
  • The founders of the DxPx Conference have always been motivated and inspired to improve the healthcare system.

BRAINBox Solutions to Participate at 2022 AACC

Retrieved on: 
Wednesday, July 6, 2022
Department, Diagnosis, FDA, Baylor University, Patient, Solution, Gold standard, Biomarker, American Association for Clinical Chemistry, Concussion, Association, Head injury, Prognosis, Risk, TBI, Clinical trial, American Association, AACC, Research, Emergency medicine, Brainbox, MD, Algorithm, Baylor College of Medicine, Conference, Medical device, Trauma

RICHMOND, Va., July 6, 2022 /PRNewswire/ -- BRAINBox Solutions today announced that at the American Association for Clinical Chemistry (AACC) Annual Scientific Meeting and Lab Expo in Chicago, July 24-28, the company will participate in two presentations, one which will take place on July 27, 2022 given by the study's principal investigator, W. Franklin Peacock, MD FACEP Professor of Emergency Medicine and Vice Chair for Research in the Department of Emergency Medicine at Baylor College of Medicine. The presentation entitled, "What will your Dr do?" will include a brief update on the ongoing HeadSMART II clinical trial (Head injury Serum markers and Multimodalities for Assessing Response to Trauma) for its concussion (mild traumatic brain injury or mTBI) diagnostic and prognostic test. The trial is the first to follow concussion patients' symptoms using a multi-modality approach over time. The presentation will focus on the characteristics of the patients enrolled to date and the impact of their injury over three months.

Key Points: 
  • The trial is the first to follow concussion patients' symptoms using a multi-modality approach over time.
  • Separately, BRAINBox CEO Donna Edmonds and Dr. Peacock will participate on a panel as part of the DX/PX Partnering Conference from 4-5 PM on July 26, 2022, entitled, "Establishing a new diagnostics gold standard in biomarkers.
  • The company's test, BRAINBox TBI, is the first objective test designed toassist in the diagnosis of concussion and provide an assessment of the risk of chronic injury.
  • BRAINBox Solutions is developing the first AIenabled, multimodality approach for the diagnosis and prognosis of Mild Traumatic Brain Injury, commonly referred to as a concussion.

Clinical Chemistry Impact Factor Rises to 12.167, the Highest in the History of the Journal

Retrieved on: 
Thursday, June 30, 2022
American Association for Clinical Chemistry, Patient, Research, Clarivate, COVID-19, Genetic testing, Clinical chemistry, Therapeutic drug monitoring, AACC, Health, Mass spectrometry, Physician, Pediatrics, Knowledge, Coronavirus, Diabetes, Pharmaceutical industry, Medical device

This impact factor places Clinical Chemistry in the top 2% of 21,430 ranked academic journals and reaffirms that it is the top journal on medical laboratory technologya position it has held for more than a decade.

Key Points: 
  • This impact factor places Clinical Chemistry in the top 2% of 21,430 ranked academic journals and reaffirms that it is the top journal on medical laboratory technologya position it has held for more than a decade.
  • As the most trusted and authoritative journal in laboratory medicine, Clinical Chemistry has supported this work by disseminating essential research on all aspects of coronavirus testing.
  • "We are thrilled to see this jump in Clinical Chemistry's impact factor," said AACC President Dr. Stephen R. Master.
  • Clinical Chemistry ( clinchem.org ) is the leading international journal of laboratory medicine, featuring nearly 400 peer-reviewed studies every year that help patients get accurate diagnoses and essential care.

Endocrine Testing Product Markets, 2022-2030 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, June 15, 2022
Biotechnology, General Health, Health, CAGR, Association, Industry, American Association, Hackensack Meridian Health, US, Cardiology, Integral Systems, Technology, American Association for Clinical Chemistry, AACC, Growth, Infection, Region, Sysmex Corporation, Marketing, Ortho Clinical Diagnostics, Quest Diagnostics, Partnership, Patient, Endocrinology, Hemostasis, Hospital Insurance and Diagnostic Services Act, Medical device, Pharmaceutical industry

The "Endocrine Testing Product Market, by Product Type, by Technology, by Test Type, by Disease Indication, by End User and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Endocrine Testing Product Market, by Product Type, by Technology, by Test Type, by Disease Indication, by End User and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • Market players are engaged in launching new products for endocrine testing products, this is expected to increase the growth of the global endocrine testing products, over the forecast period.
  • Key players are focusing on inorganic activities such as partnerships, this is expected to increase the growth of the global endocrine testing products market, over the forecast period.
  • Both the companies are indulged in supply, distributorship, and sales and partnership agreement for hemostasis products including analyzers.

The American Association for Clinical Chemistry Announces Visby Medical's Handheld PCR Diagnostic Platform as 2022 Disruptive Technology Award Finalist

Retrieved on: 
Wednesday, June 15, 2022
Association, Reproductive health, FDA, American Association, COVID-19, American Association for Clinical Chemistry, Technology, Infection, Company, Hand, Founder, AACC, LinkedIn, Twitter, Disruptive innovation, Patient, Product life-cycle theory, Diagnosis, POCT, PCR, SAN, Woman, Gonorrhea, Medical device, Pharmaceutical industry, Chlamydia, Trichomonas, Facebook

SAN JOSE, Calif., June 15, 2022 /PRNewswire/ -- The American Association for Clinical Chemistry (AACC) announced Wednesday that they have selected Visby Medical as a finalist for the 2022 Disruptive Technology Award for its handheld point-of-care PCR diagnostic technology.

Key Points: 
  • SAN JOSE, Calif., June 15, 2022 /PRNewswire/ -- The American Association for Clinical Chemistry (AACC) announced Wednesday that they have selected Visby Medical as a finalist for the 2022 Disruptive Technology Award for its handheld point-of-care PCR diagnostic technology.
  • The Company's Founder and CEO Adam de la Zerda, Ph.D., will present the technology at the Disruptive Technology Award special session during the 2022 AACC Annual Scientific Meeting on Monday, July 25 in Chicago, Illinois.
  • "Our vision, to empower anyone to test for any infection anytime in any place, drives our mission to develop innovative technology to disrupt medical diagnostics.
  • The Visby Medical technology is also helping to fight the global pandemic via the Visby Medical COVID-19 Test, and its robust pipeline includes tests for other infectious diseases.

Biological Dynamics Selected as Finalist for the 2022 AACC Disruptive Technology Award

Retrieved on: 
Tuesday, June 14, 2022
Software, Research, General Health, Oncology, Technology, Medical Devices, Genetics, Science, Nanotechnology, Biotechnology, Other Technology, Health, Other Science, Fluid mechanics, Disruptive innovation, Biomarker, Company, Urine, Cancer, Exosome, Plasma, CEO, Organic acid, Biological Dynamics of Forest Fragments Project Area of Relevant Ecological Interest, Blood, American Association, Serum, Health, Machine learning, FDA, Saliva, LabCorp, Technology, Nanoparticle, Innovation, Pall Corporation, ACE, Twitter, Association, AACC, American Association for Clinical Chemistry, Pharmaceutical industry

Biological Dynamics , Inc., a biotechnology company focused on detecting diseases at their earliest stages, today announced that the Company and its platform technology, Verita, has been selected as a 2022 finalist by the American Association for Clinical Chemistry (AACC) for their Disruptive Technology Award competition.

Key Points: 
  • Biological Dynamics , Inc., a biotechnology company focused on detecting diseases at their earliest stages, today announced that the Company and its platform technology, Verita, has been selected as a 2022 finalist by the American Association for Clinical Chemistry (AACC) for their Disruptive Technology Award competition.
  • Were honored to be selected as a finalist by the AACCs panel for this award, which recognizes the power of our differentiated multiomics platform technology, said Dr. Paul Billings, CEO and Director of Biological Dynamics.
  • AACCs Disruptive Technology Award recognizes innovative testing and disruptive technology solutions that improve patient care through diagnostic performance or access to high quality testing.
  • Biological Dynamics will present their disruptive technology to a panel of expert judges, sponsored by Labcorp and Pall Corporation, on Monday, July 25, at 4:30 p.m. CT at the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo in Chicago, IL.

Microbix Presenting Test Validation Methods at AACC

Retrieved on: 
Friday, June 3, 2022
American Association for Clinical Chemistry, Goal, Company, ISO 9001, OTCQX, TGA, News, CE, Organization, American Association, Method, FDA, GLOBE, Health Canada, U.S. FDA, Health, COVID-19, TSX, Medical device, Stock, HPV, Poster, Severe acute respiratory syndrome coronavirus 2, QAP (Colombia), Association, AACC, Engineering, Antigen, FH, Human papillomavirus infection, Vaccine, Online shopping

Microbix is attending this AACC conference to present about these important aspects of infectious disease testing, alongside leaders in the global medical diagnostics industry.

Key Points: 
  • Microbix is attending this AACC conference to present about these important aspects of infectious disease testing, alongside leaders in the global medical diagnostics industry.
  • Its poster presentation is titled Simulated Swab Specimens for Whole Workflow Quality Control of SARS-CoV-2 Molecular Diagnostic Testing.
  • Microbix creates proprietary biological products for human health, with over 100 skilled employees and sales approaching C$ 2.0 million per month.
  • Microbix is ISO 9001 and 13485 accredited, U.S. FDA registered, Australian TGA registered, Health Canada establishment licensed, and provides CE marked products.

Lysulin® Announces Lifting of FDA/FTC Warning Letter

Retrieved on: 
Friday, June 3, 2022
General Health, Health, FDA, Diabetes, Specialty, Fitness & Nutrition, Clinical Trials, Retail, American Association for Clinical Chemistry, Science, Exercise, Ullman, Health, Advertising, Nutrition, Research, Zinc, Nutrient, FTC, Food, CEO, Letter, Criticism of the Food and Drug Administration, Lysine, Blood, Insulin resistance, American Association, Physician, FDA, Risk, Association, AACC, A1C, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Protein, Dietary supplement, Dexcom

Lysulin, Inc. announced today that is has received a close-out letter from the U.S. Food and Drug Administration lifting a 2021 warning letter relating to its promotion of Lysulin dietary supplements.

Key Points: 
  • Lysulin, Inc. announced today that is has received a close-out letter from the U.S. Food and Drug Administration lifting a 2021 warning letter relating to its promotion of Lysulin dietary supplements.
  • Lysulin provides a clinically studied approach for goal-oriented blood glucose management, available in over-the-counter dietary supplements.
  • Lysulin is delivering remarkable results in nutritional support for people who want to maintain healthy glucose levels, said Burd.
  • Lysulin is committed to delivering its innovative formulation, backed by science, to help support a proactive approach to a healthy lifestyle.

Cardinal Health honors top clinical laboratory professionals

Retrieved on: 
Wednesday, April 27, 2022
MHA, COVID-19, Association, College, Research, Cardinal, CAH, Diagnosis, Program, Patient safety, Efficiency, COVID-19 testing, National Geographic, School, Public health, American Association, Multimedia, RBC, Ohio State University Wexner Medical Center, Trust, Health, OSU, CNBC, Scene (filmmaking), MLS, Leukemia, Infection, Doctor of Philosophy, AHI, View, American Society for Clinical Laboratory Science, Cardinal Health, ASCP, American Association for Clinical Chemistry, Awareness, Medical laboratory, Workflow, Leadership, SVCM, Health technology, MPA, Safety, Ohio State University, CLS, Forbes, University, Comanche County, Laboratory, Family, AMT, Culture, Student, NYSE, Regent, Pharmaceutical industry, Medicine, Medical device, Kronos

DUBLIN, Ohio, April 27, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced the winners and honorees of its annual Lab Excellence List, which names top clinical laboratory professionals making significant contributions to health care and patient outcomes through their research, diagnosis, innovation or advocacy.

Key Points: 
  • DUBLIN, Ohio, April 27, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced the winners and honorees of its annual Lab Excellence List, which names top clinical laboratory professionals making significant contributions to health care and patient outcomes through their research, diagnosis, innovation or advocacy.
  • The list is part of celebrations surrounding the industry's annual Medical Laboratory Professionals Week, a more than 40-year-long tradition that celebrates lab professionals across all of health care.
  • "On behalf of Cardinal Health, I want to say thank you to lab professionals everywhere for their essential contributions to laboratory medicine."
  • (In 2015, Rohde was honored as the Cardinal Health urEssential Laboratory Professional of the Year , a now-retired award program that recognized the vital contributions medical laboratory professionals made to patient care.)